ロード中...

Long-term Survival With Afatinib in a Patient With Lung Adenocarcinoma Harboring Double Uncommon EGFR L861Q and G719X Mutations

Background: In the majority of non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations, first generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are ineffective. The second-generation TKI, afatinib, is considered effective in patients with uncommon mu...

詳細記述

保存先:
書誌詳細
出版年:In Vivo
主要な著者: OHARA, GEN, OKAUCHI, SHINICHIRO, SASATANI, YUIKA, SHIOZAWA, TOSHIHIRO, YAMADA, HIDEYASU, MIYAZAKI, KUNIHIKO, SATOH, HIROAKI
フォーマット: Artigo
言語:Inglês
出版事項: International Institute of Anticancer Research 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279823/
https://ncbi.nlm.nih.gov/pubmed/32354946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11929
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!